BioScrip, Inc.

BioScrip, Inc. Reports 2009 First Quarter Earnings of $0.08 Per Share

Published in Health Business Week, May 22nd, 2009

BioScrip, Inc. (Nasdaq: BIOS) announced first quarter net income of $3.3 million, or $0.08 per diluted share, on revenue of $325.7 million. These results compare to a net loss of $0.5 million, or $0.01 per share, on revenue of $327.5 million for the first quarter of 2008. First quarter 2009 EBITDAO was $6.2 million compared to $2.7 million for the same period a year ago.

Richard H. Friedman, BioScrip’s Chairman and Chief Executive Officer, stated, "During the quarter, we strengthened our management organization, delivered on margin expansion, met our annual cost reduction target and increased our operating cash flows. Operationally we continue to expand our national...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2009-05-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry